BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 23520186)

  • 1. Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry disease.
    Krämer J; Niemann M; Liu D; Hu K; Machann W; Beer M; Wanner C; Ertl G; Weidemann F
    Eur Heart J; 2013 Jun; 34(21):1587-96. PubMed ID: 23520186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of Myocardial Fibrosis: Revealing the Natural History of Fibrogenesis in Fabry Disease Cardiomyopathy.
    Aguiar P; Azevedo O; Pinto R; Marino J; Cardoso C; Sousa N; Cunha D; Hughes D; Ducla Soares JL
    J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29535138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myofilament degradation and dysfunction of human cardiomyocytes in Fabry disease.
    Chimenti C; Hamdani N; Boontje NM; DeCobelli F; Esposito A; Bronzwaer JG; Stienen GJ; Russo MA; Paulus WJ; Frustaci A; van der Velden J
    Am J Pathol; 2008 Jun; 172(6):1482-90. PubMed ID: 18467700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of enzyme replacement therapy and migalastat on left atrial strain and cardiomyopathy in patients with Fabry disease.
    Pogoda C; Brand SM; Duning T; Schmidt-Pogoda A; Sindermann J; Lenders M; Brand E
    Front Cardiovasc Med; 2023; 10():1223635. PubMed ID: 38028489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabry Disease: More than a Phenocopy of Hypertrophic Cardiomyopathy.
    Stankowski K; Figliozzi S; Battaglia V; Catapano F; Francone M; Monti L
    J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radial basis functions for combining shape and speckle tracking in 4D echocardiography.
    Compas CB; Wong EY; Huang X; Sampath S; Lin BA; Pal P; Papademetris X; Thiele K; Dione DP; Stacy M; Staib LH; Sinusas AJ; O'Donnell M; Duncan JS
    IEEE Trans Med Imaging; 2014 Jun; 33(6):1275-89. PubMed ID: 24893257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of two dimensional speckle tracking echocardiography in determining cardiac prognosis and monitoring enzyme replacement therapy efficacy in patients with Anderson-Fabry disease.
    Nabati M; Parsaee H
    J Clin Ultrasound; 2024 Jan; 52(1):30-31. PubMed ID: 38053509
    [No Abstract]   [Full Text] [Related]  

  • 8. Uncertainty Quantification of Regional Cardiac Tissue Properties in Arrhythmogenic Cardiomyopathy Using Adaptive Multiple Importance Sampling.
    van Osta N; Kirkels FP; van Loon T; Koopsen T; Lyon A; Meiburg R; Huberts W; Cramer MJ; Delhaas T; Haugaa KH; Teske AJ; Lumens J
    Front Physiol; 2021; 12():738926. PubMed ID: 34658923
    [No Abstract]   [Full Text] [Related]  

  • 9. A case of neonatal fulminant myocarditis with dystrophic calcification: Usefulness of two-dimensional speckle-tracking echocardiography.
    Furui S; Sato T; Seki M
    J Cardiol Cases; 2024 Mar; 29(3):108-111. PubMed ID: 38481640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlations Between Cardiac Magnetic Resonance and Myocardial Histologic Findings in Fabry Disease.
    Ditaranto R; Leone O; Lovato L; Niro F; Cenacchi G; Papa V; Baldovini C; Ferracin M; Salamon I; Kurdi H; Parisi V; Capelli I; Pession A; Liguori R; Potena L; Seri M; Martin Suarez S; Galiè N; Moon JC; Biagini E
    JACC Cardiovasc Imaging; 2023 Dec; 16(12):1629-1632. PubMed ID: 37542504
    [No Abstract]   [Full Text] [Related]  

  • 11. Stress-Mediated Abnormalities in Regional Myocardial Wall Motion in Young Women with a History of Psychological Trauma.
    Aweimer A; Engemann L; Amar S; Ewers A; Afshari F; Maiß C; Kern K; Lücke T; Mügge A; El-Battrawy I; Dietrich JW; Brüne M
    J Clin Med; 2023 Oct; 12(21):. PubMed ID: 37959168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiography in Fabry disease: how many dimensions do we need?
    Voigt JU
    Eur Heart J Cardiovasc Imaging; 2023 Nov; 24(12):1638-1639. PubMed ID: 37418491
    [No Abstract]   [Full Text] [Related]  

  • 13. Retracted: Application Effect and Evaluation of Two-Dimensional Speckle Tracking Imaging on Myocardial Damage in Patients with Malignant Lymphoma Treated with Anthracyclines.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9861617. PubMed ID: 37387858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fusion imaging of three-dimensional echocardiographic speckle-tracking with cardiac computed tomography for identification of myocardial ischemia.
    Takaya Y; Nakayama R; Watanabe N; Toh N; Miyoshi T; Ito H
    Health Sci Rep; 2021 Jun; 4(2):e285. PubMed ID: 34189272
    [No Abstract]   [Full Text] [Related]  

  • 15. Proposed Stages of Myocardial Phenotype Development in Fabry Disease.
    Nordin S; Kozor R; Medina-Menacho K; Abdel-Gadir A; Baig S; Sado DM; Lobascio I; Murphy E; Lachmann RH; Mehta A; Edwards NC; Ramaswami U; Steeds RP; Hughes D; Moon JC
    JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1673-1683. PubMed ID: 29778854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage.
    Augusto JB; Johner N; Shah D; Nordin S; Knott KD; Rosmini S; Lau C; Alfarih M; Hughes R; Seraphim A; Vijapurapu R; Bhuva A; Lin L; Ojrzyńska N; Geberhiwot T; Captur G; Ramaswami U; Steeds RP; Kozor R; Hughes D; Moon JC; Namdar M
    Eur Heart J Cardiovasc Imaging; 2021 Jun; 22(7):790-799. PubMed ID: 32514567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Layer-specific longitudinal strain in Anderson-Fabry disease at diagnosis: A speckle tracking echocardiography analysis.
    Esposito R; Santoro C; Sorrentino R; Riccio E; Citro R; Buonauro A; Di Risi T; Imbriaco M; Trimarco B; Pisani A; Galderisi M;
    Echocardiography; 2019 Jul; 36(7):1273-1281. PubMed ID: 31246327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of echocardiography for differential diagnosis of left ventricular hypertrophy: special focus on speckle-tracking longitudinal strain.
    Tanaka H
    J Echocardiogr; 2021 Jun; 19(2):71-79. PubMed ID: 33460030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of base-to-apex circumferential strain gradient assessed by cardiovascular magnetic resonance in Fabry disease: relationship to T1 mapping, late gadolinium enhancement and hypertrophy.
    Mathur S; Dreisbach JG; Karur GR; Iwanochko RM; Morel CF; Wasim S; Nguyen ET; Wintersperger BJ; Hanneman K
    J Cardiovasc Magn Reson; 2019 Aug; 21(1):45. PubMed ID: 31366357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early detection of organ involvement in Fabry disease by biomarker assessment in conjunction with LGE cardiac MRI: results from the SOPHIA study.
    Weidemann F; Beer M; Kralewski M; Siwy J; Kampmann C
    Mol Genet Metab; 2019 Feb; 126(2):169-182. PubMed ID: 30594474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.